GlassScriptPhysician profile
Scott A Handley
NPI 1316949209
$3,839.93
in general payments reported to CMS, 2019-2025
29 companies · $632 in 2025
The $632 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,014 · 2020: $386 · 2021: $531 · 2022: $357 · 2023: $618 · 2024: $303 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,552.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $918.27 | 2020-2025 | Puraply, Apligraf, Novachor |
| Smith+Nephew, INC. | $625.43 | 2019-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Stryker Corporation | $283.56 | 2021-2023 | Prostep, Prophecy |
| Acumed LLC | $244.48 | 2022-2024 | Osteomed, Acumed, Inion Freedompin |
| Sebela Pharmaceuticals INC. | $215.12 | 2019-2023 | Naftin |
| Osteomed LLC | $189.89 | 2019-2022 | |
| Integra Lifesciences Corporation | $174.20 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $169.32 | 2019-2022 | |
| Horizon Therapeutics Plc | $168.76 | 2019-2020 | |
| Orthofix Medical, INC. | $158.33 | 2019-2022 | |
| Wright Medical Technology, INC. | $132.12 | 2019 | |
| Biocomposites INC | $93.19 | 2025 | Stimulan |
| Paratek Pharmaceuticals, INC. | $91.38 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $38.90 | 2019 | |
| Melinta Therapeutics, LLC | $35.07 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $34.74 | 2020-2022 | |
| Nabriva Therapeutics, Plc | $30.35 | 2021 | |
| Kerecis Limited | $28.55 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $26.06 | 2019 | |
| Hydrofera LLC | $23.26 | 2024 | Cutimed Sorbact |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.33 | 2021 | |
| Bioventus LLC | $19.64 | 2019 | |
| Heron Therapeutics, INC. | $18.94 | 2021 | |
| Allergan, INC. | $18.56 | 2020 | |
| Tactile Systems Technology INC | $18.30 | 2024 | Entre Plus, Flexitouch Plus |
| Osiris Therapeutics INC. | $18.00 | 2019 | |
| Alfasigma USA, INC. | $16.90 | 2021 | |
| Abbvie INC. | $15.19 | 2021 | |
| Medline Industries LP | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Handley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.